The Global Gerd Drugs And Devices Market report provides full coverage of the companies’ data, including details about their production and manufacturing capacity, product portfolio, business overview, revenue, gross profit margins, sales network and distribution channel, financial standing, and market position .The report also studies business strategies and strategic alliances undertaken by companies to footing in the gain a robust market. The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals.
The report is updated with the latest economic scenario and market scope with regard to the ongoing COVID-19 pandemic. The report covers growth prospects as well as current and futuristic revenue estimations in a post COVID scenario. The report also covers changing trends and market dynamics due to the pandemic and provides an accurate impact analysis of the crisis on the overall market.The growing demand for OTC and generic drugs and the rise in the geriatric population will drive the GERD drugs and devices market.
Market Dynamics:
The report offers insightful information about the market dynamics of the Gerd Drugs And Devices market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Gerd Drugs And Devices market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Gerd Drugs And Devices market.
Get a Free sample of the report : https://www.emergenresearch.com/request-sample/383
Gastroesophageal Reflux Disease is growing due to the intake of analgesics, smoking, decrease in the prevalence of Helicobacter pylori infection, consumption of certain types of food and drinks, high body mass index (BMI), family history of GERD, and limited physical activity. The growing incidence of the disease will drive the demand for the GERD drug and devices market.
Some Key Highlights from the Report
In November 2020, Sandoz Inc. announced it had shipped pantoprazole sodium to supply the hospitals for injection, 40 mg to Civica Rx. It is a part of a multiyear collaboration for the reduction in supply shortages with several other pipeline medicines.
H2 blockers are a group of drugs that reduces the amount of acid produced by the cell lining of the stomach. They are also known as histamine H2-receptor antagonists but are also known as H2 blockers. They include ranitidine, cimetidine, nizatidine, and famotidine, among others.
The MUSE or Medigus Ultrasonic Surgical Endostapler is an extensive endoscopic device that incorporates the latest technological advancement for the delivery of patient-friendly option for Transoral Fundoplication, the procedure intended for the treatment of GERD.
North America held the largest share, with the U.S. contributing the major revenue share. The rise in the geriatric population in the region, which is prone to acid reflux and development in heartburn, will drive the demand of the Gastroesophageal Reflux Disease Drugs and Devices market
Key participants include Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others.
Radical Highlights of the Gerd Drugs And Devices Market Report:
Comprehensive overview of the Gerd Drugs And Devices market along with analysis of the changing dynamics of the market
Growth Assessment of various market segments throughout the forecast period
Regional and global analysis of the market players, including their market share and global position
Growth strategies adopted by key market players to combat the impact of the COVID-19 pandemic on the market
Impact of the technological developments and R&D advancements on the Gerd Drugs And Devices market
Information about profit-making strategies and developmental strategies of major companies and manufacturers
Insightful information for the new entrants willing to enter the market
Details and insights about business expansion strategies, product launches, and other collaborations
The report incorporates advanced analytical tools such as SWOT analysis, Porter’s Five Forces Analysis, feasibility analysis, and investment return analysis
Request customization of the report: https://www.emergenresearch.com/request-for-customization/383
For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, device type, and region:
Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
- Oral
- Parenteral
Drug Type Outlook (Revenue, USD Billion; 2017-2027)
- H2 Receptor Antagonist
- Proton Pump Inhibitor (PPIs)
- Antacids
Device Type Outlook (Revenue, USD Billion; 2017-2027)
- MUSE –Medigus Ultrasonic Surgical Endostapler
- LINX Management System
- Stretta Therapy
- Bravo Reflux Testing System
- Digitrapper reflux testing system
- Others
Read More: https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
Related Reports:
rfid in healthcare market
nucleic acid isolation and purification market
non-invasive prenatal testing market
in-vitro fertilization market
medical image analytics market
joint reconstruction devices market
precision medicine market
microfluidics market
https://www.google.al/url?q=https://www.emergenresearch.com/industry-report/microfluidics-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
